| Amy Jean Wolford, APN | |
|
14340 Torrey Chase Blvd, Suite 160, Houston, TX 77014-1021 | |
| (281) 580-8086 | |
| (281) 580-7129 |
| Full Name | Amy Jean Wolford |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Psychiatric/mental Health |
| Location | 14340 Torrey Chase Blvd, Houston, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013033018 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0808X | Clinical Nurse Specialist - Psychiatric/mental Health | 01404 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amy Jean Wolford, APN 14340 Torrey Chase Blvd, Suite 160, Houston, TX 77014-1021 Ph: (281) 580-8086 | Amy Jean Wolford, APN 14340 Torrey Chase Blvd, Suite 160, Houston, TX 77014-1021 Ph: (281) 580-8086 |
News Archive
Teva Women's Health, Inc. announced today that its Plan B® One-Step (levonorgestrel) tablet, 1.5 mg emergency contraceptive is now available at licensed U.S. retail pharmacies. Approved by the U.S. Food and Drug Administration (FDA) on July 10, Plan B® One-Step can help prevent an unintended pregnancy after unprotected sex or contraceptive failure with just one pill in one dose.
The current leading method to assess the presence of viruses and other biological markers of disease is effective but large and expensive. It is prohibitively difficult for use in many situations, especially due to certain economic and geographic factors.
Researchers have identified an approach to remove race from equations used to estimate a person's kidney function. These equations have been criticized for potentially perpetuating racial health disparities. The findings, reported September 23 in the New England Journal of Medicine, are expected to inform National Kidney Foundation–American Society of Nephrology Task Force guidelines on evaluating kidney function.
African-American race is a distinct risk factor for developing life-threatening blood clots after receiving a drug-coated stent, according to research reported in Circulation: Journal of the American Heart Association.
Amgen Senior Vice President of Research and Development Joe Miletich, M.D., Ph.D., will urge members of a U.S. Food and Drug Administration (FDA) panel charged with implementing a pathway for biosimilars to establish approval standards that ensure patient safety and follow a science-based approach.
› Verified 2 days ago
Stephanie Quintero, MSN, APRN, AG CNS-BC Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 1515 Holcombe Blvd, Houston, TX 77030 Phone: 713-792-6161 | |
Cuong Thi Thanh Phan, Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 7401 Main St, Houston, TX 77030 Phone: 713-799-2300 Fax: 713-794-3380 | |
Margaret A. Mcmartin, CNS-P/MH-LPA Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1311 Antoine Dr Apt 283, Houston, TX 77055 Phone: 713-208-0456 | |
Paula F. Demasi, RN, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1515 Holcombe Blvd, Houston, TX 77030 Phone: 713-792-6161 | |
Martha Wimberly Oloomi, APRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 2002 Holcombe Blvd, Sci/rehab/neuro Service Line, Houston, TX 77030 Phone: 281-980-0465 | |
Dona Marie Gambrel, APRN, BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 9401 Southwest Fwy, Houston, TX 77074 Phone: 713-448-6986 Fax: 713-448-5746 |